Medtide Inc. filed its Monthly Return for the period ended 30 April 2026 with Hong Kong Exchanges and Clearing on 6 May 2026, reporting no movements in either authorised or issued share capital.

The company’s issued H-share capital remains at 141.80 million ordinary shares with a par value of RMB 1 each, representing RMB 141.80 million in total issued share capital. No treasury shares were outstanding, and there were no new issues, repurchases, cancellations or conversions during the month.

Medtide confirmed that its public float continues to satisfy the Main Board’s minimum requirement of 25% of outstanding H shares, based on publicly available information.

The filing also notes that throughout April 2026 the company had no outstanding share options, warrants, convertible securities or other agreements that could dilute existing share capital. The return was authorised and signed by Joint Company Secretary Ng Tung Ching Raphael.